The cardiotropic properties of ZMEI-3 compound – a potential inhibitor of Epac proteins

Introduction. It is known that the allosteric effector of cAMP, in addition to protein kinase A, is the Epac regulatory proteins, which in cardiomyocytes play a key role in the electromechanical coupling control and their rhythmic activity. However, under pathological conditions, abnormal activity o...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	S. A. Kryzhanovskii, G. V. Mokrov, I. B. Tsorin, E. O. Ionova, M. B. Vititnova, V. N. Stolyaruk, I. A. Miroshkina, A. V. Sorokina, A. D. Durnev
Fformat:	Artigo
Iaith:	Russo
Cyhoeddwyd:	LLC “Publisher OKI” 2025-01-01
Cyfres:	Фармакокинетика и Фармакодинамика
Pynciau:	epac proteins epac protein antagonists compound zmei-3 cardiac arrhythmias alcoholic cardiomyopathy myocardial contractility rats
Mynediad Ar-lein:	https://www.pharmacokinetica.ru/jour/article/view/437
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!